Answer
Taltz (ixekizumab) is contraindicated in serious hypersensitivity to ixekizumab or any listed excipient, and in clinically important active infections, such as active tuberculosis.
Sources for this answer
- Taltz 80 mg solution for injection in pre-filled penEli Lilly and Company Limited · emc · SmPC §4.3 Contraindications · Version 19Document updated
Sources checked